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Abstract
Background: Inflammatory injury plays a critical role in intracerebral hemorrhage (ICH)-induced neurological
deficits; however, the signaling pathways are not apparent by which the upstream cellular events trigger innate
immune and inflammatory responses that contribute to neurological impairments. Toll-like receptor 4 (TLR4) plays
a role in inflammatory damage caused by brain disorders.
Methods: In this study, we investigate the role of TLR4 signaling in ICH-induced inflammation. In the ICH
model, a significant upregulation of TLR4 expression in reactive microglia has been demonstrated using real-
time RT-PCR. Activation of microglia was detected by immunohistochemistry, cytokines were measured by
ELISA, MyD88, TRIF and NF-B were measured by Western blot and EMSA, animal behavior was evaluated by
animal behavioristics.
Results: Compared to WT mice, TLR4
−/− mice had restrained ICH-induced brain damage showing in reduced
cerebral edema and lower neurological deficit scores. Quantification of cytokines including IL-6, TNF-a and IL-1b
and assessment of macrophage infiltration in perihematoma tissues from TLR4
−/−, MyD88
−/− and TRIF
−/− mice
showed attenuated inflammatory damage after ICH. TLR4
−/− mice also exhibited reduced MyD88 and TRIF
expression which was accompanied by decreased NF-B activity. This suggests that after ICH both MyD88 and TRIF
pathways might be involved in TLR4-mediated inflammatory injury possibly via NF-B activation. Exogenous hemin
administration significantly increased TLR4 expression and microglial activation in cultures and also exacerbated
brain injury in WT mice but not in TLR4
−/− mice. Anti-TLR4 antibody administration suppressed hemin-induced
microglial activation in cultures and in the mice model of ICH.
Conclusions: Our findings suggest that heme potentiates microglial activation via TLR4, in turn inducing NF-B
activation via the MyD88/TRIF signaling pathway, and ultimately increasing cytokine expression and inflammatory
injury in ICH. Targeting TLR4 signaling may be a promising therapeutic strategy for ICH.
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Intracerebral hemorrhage (ICH) is a common and ser-
ious acute cerebrovascular disease (CVD), accounting
for approximately 10-15% of CVD cases. Incidence,
fatality and disabling rate are high for ICH, and most of
the survivors suffer from apparent disability. Although
there is a significant body of research on the events fol-
lowing ICH, the signaling pathways by which the initial
cellular events trigger innate immune and inflammatory
responses that contribute to neurological impairments
are not apparent [1-3]. Following ICH, a progressive
inflammatory process arises from perihematoma edema
[4-7], where blood infiltrating the brain parenchyma
leads to disruption of the blood-brain barrier (BBB) [8],
infiltration of neutrophil and macrophage [9], hematoma
expansion [10] and ultimately neuronal death.
Innate immunity and inflammatory responses may
contribute to neurological deficits possibly through
release of endogenous ligands, which exert functions lar-
gely through Toll-like receptors (TLRs) [11,12]. TLRs
were the first and well characterized pattern-recognition
receptors (PRRs) to be identified. To date, 10 and 13,
respectively, functional TLRs which recognize distinct
PAMPs derived from viruses, bacteria, mycobacteria,
fungi and parasites have been identified in humans and
in mice, respectively [13,14]. Upon recognition of
respective PAMPs, TLRs recruit a specific set of adaptor
molecules that harbor the TIR domain, such as MyD88
and TRIF, and initiate downstream signaling events
including nuclear factor kappa B (NF-B) that leads to
the expression of gene encoding inflammation-asso-
ciated molecules and cytokines [15]. TLR4 interacts with
the adapter protein myeloid differentiation factor 88
(MyD88) or/and TIR-domain-containing adapter-indu-
cing interferon-b (TRIF) to activate NF-B, which regu-
lates the gene expression of inflammatory mediators
such as the cytokines interleukin (IL)-1a and-1b, tumor
necrosis factor (TNF)-a, and IL-6 [16,17]. Recently, it
has been demonstrated that TLR4 contributes to inflam-
matory injury in central nervous system infection and
cerebral ischemia [18,19]. TLR4 is an important contri-
butor to microglial activati o na n dk n o w nt oi n i t i a t ea n
inflammatory cascade in response to various brain inju-
ries. However, the role of TLR4 in ICH-induced inflam-
matory injury remains unclear.
In the hemorrhage brain, erythrocyte lysis occurs fol-
lowing an intracerebral bleed [6,10], releasing free heme
(iron protoporphyrin IX), which is degraded by heme
oxygenase into ferrous iron, carbon monoxide, and bili-
verdin. Iron overload and hemoglobin toxicity has been
thought to contribute to microglia activation, brain
edema, oxidative stress, and upregulation of cytokine
expression [4,5,7]. A recent report suggests that heme
activates TLR4 to induce TNF-a secretion [20]. Also,
after ICH, upregulation of TLR4 and activation of NF-
B in perihematoma tissues have been reported [21,22].
However, the exact mechanism of the TLR4 signaling
pathway in ICH is not fully understood. Therefore, we
propose a hypothesis that following ICH, hematoma
components (i.e. heme) may act on TLR4 expressed on
inflammatory cells, and activate gene transcription
through the TLR4 downstream signaling pathway, which
results in the production of inflammatory factors and
ultimately leads to inflammatory injury and neurological
deficits. To test this hypothesis, we investigated in this
study the role of TLR4 in ICH-induced inflammatory
injury and explore the endogenous trigger and possible
signaling pathway involved in TLR4-mediated inflamma-
tory response following ICH.
Materials and methods
Animals
C57BL/6 mice (male, 8-10 weeks, 20-24 g) were
obtained from the Animal Center of the Third Military
Medical University (Chongqing, China). Transgenic line
TLR4
−/−,M y D 8 8
−/− and TRIF
−/− mice (8-10 weeks, 21-
22 g) were purchased from American Jackson Labora-
tories (Bar Harbor, ME, USA) and were backcrossed to
aC 5 7 B L / 6m o r et h a n8t i m e s .A n i m a l sw e r eh o u s e di n
individual cages with free access to sterile acidified
water and irradiated food in a specific pathogen-free
facility at the Third Military Medical University. Experi-
ments were conducted in accordance with animal care
guidelines approved by the Animal Ethics Committee of
the Third Military Medical University.
Mouse model of intracerebral hemorrhage (ICH)
A modified mouse model of ICH was used [23]. Mice
were anesthetized with intraperitoneal chloral hydrate
(40 mg/kg) and placed in a stereotaxic frame (Stoelting,
Kiel, WI, USA). A micro-sample instrument was low-
ered into the center of the striatum by craniotomy
under stereotactic guidance at the following coordinates
relative to bregma: 1 mm anterior, 2.5 mm lateral, and 4
mm deep. A volume of 25 μL of autologous whole
blood was infused at 2.5 μL/min over a period of 10
min. The needle was held in place for another 10 min
after the infusion to prevent leakage. Craniotomy was
then sealed with bone wax, and the scalp was closed
with suture. Control mice were infused with 25 μLo f
0.9% saline. We maintained the room temperature at
about 25°C during and after surgery, and exposed the
animals to incandescent lighting to keep their rectal
temperature at 37 ± 1°C until palinesthesia. An arterial
catheter to measure arterial blood pressure (MABP) was
placed in the femoral artery. Physiological parameters
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cose (mg/dL), arterial pH, arterial pO2, base excess, Hb
(g/L), Laser Doppler, and body weight (g) were mea-
sured 30 minutes before and after ICH modeling. Treat-
ment of ICH did not affect these parameters to a
significant extent. Different experimental groups were
included: WT sham (n =6 9 ) ,W TI C H( n = 51), TLR4
−/− sham (n = 15), TLR4
−/− ICH (n = 39), MyD88
−/−
sham (n = 6), MyD88
−/− ICH (n = 12), TRIF
−/− sham (n
=6 ) ,T R I F
−/− ICH (n =1 2 ) .S o m em i c ew e r eu s e df o r
several experiments.
In order to investigate the effect of TLR4 depletion on
heme-induced inflammation, 25 μL of hemin (Lundbeck
Inc., Deerfield, IL 60015, USA, reconstituted with sterile
water to a concentration of approximately 7 mg/mL.
NDC numbers: 67386-701-54. Lot No: 14674-Z7.) was
injected into the striatum in mice as described pre-
viously [24]. The mice were subjected to experiments 24
h later. The doses The used in this experiment were
determined according to the literature [24] and accord-
ing to our ex vivo study in which these doses led to sig-
nificant cerebral edema and neurological deficits in
mice. In the control group, 25 μL of vehicle (sterile buf-
fer of 5 mg/ml sodium carbonate and 6.98 mg/ml of
sorbitol) was injected.
Real-time reverse transcription polymerase chain reaction
(real-time RT PCR)
Total RNA was extracted from perihematoma tissues,
about 4 × 4 × 4 mm
3 volume (blood clot as core under a
stereomicroscope) on day 1, 2, 3, and 5 post-ICH accord-
i n gt op r e v i o u sm e t h o d s[ 2 5 ]a n df r o mm i c r o g l i a lc u l -
tures using Trizol reagent (Invitrogen, Gaithersburg, MD,
USA) according to the manufacturer’s instructions.
cDNA was synthesized using the iScript cDNA Synthesis
Kit (Bio-Rad) and the real-time RT-PCR was carried out
on a Biorad I-Cycler with the IQ
TM SYBER
® Green
Supermix (Bio-Rad) in 96-well plates. Primers were pur-
chased from Shanghai Sangon Biological Engineering
(Shanghai, China). The primer sequences were as follows:
TLR4, forward: 5’-GTCAGTGTGATTGTGGTATCC-3’,
reverse: 5’-ACCCAGTCC-TCATTCTGACTC-3’.T o
quantify measurements of gene expression, a threshold
cycle value (CT) was calculated, using the ΔΔ CT method
as previously described [26].
Immunohistochemical staining
On day 1, 2, 3, and 5 post-ICH, mice were anesthetized
and intracardially perfused with phosphate buffered sal-
ine (PBS), followed by 4% paraformaldehyde (PFA) as
described previously [27,28]. Brains were removed and
post-fixed in 4% PFA at 4°C overnight. Thirty micro
brain sections were obtained with microtome. Double-
fluorescent immunohistochemistry was performed to
identify TLR4 expression in tissue according the con-
ventional immunostaining method. Primary antibodies
used in this experiment included: goat anti-mouse TLR4
(1:200, Abcam, Cambridge, UK), rabbit anti-mouse bIII-
tubulin (1:1000, Abcam Cambridge, UK), rat anti-mouse
CD11b (1:200, eBioscience San Diego, CA, USA) and
rabbit anti-mouse GFAP (1:1000, Abcam Cambridge,
UK). Secondary antibodies included Alexa Flour
® 488
(goat anti-rat IgG (H + L), goat anti-rabbit IgG (H + L)
and Alexa Flour
® 546 (donkey anti-goat IgG (H + L);
Invitrogen, Carlsbad, CA, USA). Quantification of
immunohistochemistry was performed as previously
described, the results were shown as “%a r e ao fp e r i h e -
matoma tissue region positive” [29]. TLR4-positive cells
were accessed blindly and a scale of 0, 1, 2, 3, 4 and 5,
respectively, indicates the area-percent with an expres-
sion of 0%, ≤10%, 11-25%, 26-45%, 46-75%, and >76%,
respectively.
To assess macrophage infiltration, brain sections were
incubated with rabbit anti-mouse CD68 (1:200, Abcam,
C a m b r i d g e ,U K )a t4 ° Co v e r n i g h ta n dt h ea n t i - r a b b i t
HRP/DAB detection system was used to visualize the
expression. Three sections were prepared for each brain
tissue specimen obtained from the perihematoma region
and CD68-positive macrophages were counted within 20
consecutive high-power fields (×400) as previously
described [29]. Cell counting was performed by two
independent observers in a blind manner. Images were
acquired using a digital confocal microscope (Leica TCS
Sp5, Mannheim, Germany) and Nikon optical micro-
scope (Nikon Eclipse 90i, Tokyo, Japan). IPP 6. 0 image
processing software was used to count the number of
CD68-positive cells. Image analysts were blind to all the
experiments.
Neurological deficit scores
After 3 day post ICH modeling, the mice were in stable
condition, the neurological deficit tests were performed
by behavioral measurement, including postural flexing
test, circling or sidewalk, forelimb placing and foot fault
test and repeated 3 times according to the method by
Zhao X et al. [30].
Measurement of cerebral water content of mice
To measure cerebral water content after ICH, mice were
randomly selected from each group and euthanized. We
levered the skull within 1 minute to take out brain tis-
sues, blotted up the water on the surface of the left
hemisphere with filter paper, and took the humid
weights (GW) on an electronic balance. We then dried
them for 24-48 h at 95°-100°C in an Electro-Thermo-
static Blast Oven and took their dry weights (DW). Cer-
ebral water contents were calculated by the formula:
cerebral water content% = (GW - DW)/GW × 100%.
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ELISA was performed as per the manufacturer’s instruc-
tions (Dakewe Biotech, Shenzhen, China) to assess the
concentrations of TNF-a, IL-6, and IL-1b in brain tis-
sues obtained from the perihematoma region. Brain tis-
sues (80 mg) were centrifuged at 12000 g and the
supernatant was collected for analysis. The detection
threshold of this assay was <1 pg/mL.
Western blot analysis
Western blot analysis was performed as previously
described [31]. Briefly, proteins were separated from
perihematoma tissues (80 mg) or microglia (1 × 10
5)b y
SDS polyacrylamide gel electrophoresis and transferred
onto polyvinylidene fluoride (PVDF) membranes (Amer-
sham Pharmacia). The PVDF membranes were incu-
bated with the primary antibodies, including: rabbit
anti-mouse MyD88 (for perihematoma tissues, 1:500,
Abcam, Cambridge, UK), rabbit anti-mouse TRIF (for
perihematoma tissues, 1:500, Abcam, Cambridge, UK)
and rabbit anti-mouse TLR4 (for microglia, 1:500,
Abcam, Cambridge, UK), followed by incubation with
peroxidase-conjugated secondary antibodies (1:2000,
Jingmei, China). The signals were detected with an ECL
system (Amersham Pharmacia). The same membranes
were probed with antibody for glyceradehyde-3-phos-
phate dehydrogenase (GAPDH) after being washed with
stripping buffer. The signals were quantified by scanning
densitometry and computer-assisted image analysis.
Determination of NF-B activity by electrophoretic
mobility shift assay
Electrophoretic mobility shift assay was performed as
previously described [31,32]. Nucleoprotein was
extracted from brain tissue according to the manufac-
turer’s instructions. Ten microgram of nucleoprotein of
each sample was incubated with the reaction buffer at
room temperature for 15 min, then P
32-labeled oligonu-
cleotide (5’-GGGGACTTTCC-3’; Life Technologies,
G a i t h e r s b u r g ,M D ,U S A ) ,w h i c hb i n d st oN F - B, was
added to the reaction buffer and incubated for 15 min.
A f t e ri n c u b a t i o nf o r2 0m i na t2 5 ° C ,t h er e a c t i o nm i x -
ture was subjected to 6% non-denaturing polyacrylamide
gel electrophoresis. Autoradiography was performed at
room temperature. Finally, the images were analyzed
using an Bio-Rad Image Analyzer (CA, USA) and the
results were expressed as optical density (OD).
Microglia culture and treatment
Primary microglia culture was performed as previously
described [33]. Cerebral hemispheres of 1-day old post-
natal mice (both wild type and TLR4
−/− mice) were
digested with 0.1% trypsin. The cells were seeded into a
six-well plate coated with poly-L-lysine and fed with
Dulbecco’s Modified Eagle Media (DMEM; Sigma, St.
Louis, MO, USA) containing 10% fetal bovine serum
( F B S ;H y c l o n e ,L o g a n ,U T / U S A ) .C u l t u r em e d i aw e r e
refreshed twice per week for 2 weeks. Microglia were
detached by gentle shaking and filtered through a nylon
mesh to remove astrocytes. After centrifugation at 1000
× g for 10 min, the cells were resuspended in fresh
D M E Ms u p p l e m e n t e dw i t h1 0 %F B Sa n dp l a t e da ta
final density of 5 × 10
5 cells/mL on a poly-L-lysine-
coated 6-well culture plate. The following day, cells
were subjected to the experiments. The cell purity was
determined by immunohistochemical staining using
microglia specific antibody CD11b. The microglia cul-
tures used were >95% pure.
To assess the TLR4 expression after stimulation, WT
microglia were stimulated with 30 μM each of hemin,
bilirubin (Sigma, Shanghai, China), Fe
2+ (FeSO4,S i g m a ,
Shanghai, China) for 24 h. Western blot was used to
assess TLR4 expression. To determine the activation of
microglia after stimulation, 30 μM each of hemin, biliru-
bin, FeSO4, LPS((100 ng/mL), hemin + polymyxin B
(PB, New Bedford Laboratorie, MA, USA; 20 μg/mL)
and LPS + PB for 24 h, TNF-a release was determined
by ELISA.
To further evaluate microglial activation in response
to stimulus, microglial cultures from WT and TLR4
−/−
were stimulated for 24 h with 1) vehicle, 2) 30 μMo f
hemin. WT microglial cells were also stimulated with
combinations of 3) Hemin + 10 μg/mL anti-TLR4
monoclonal unconjugated antibody Mts510 (LifeSpan
BioSciences, Seattle, WA, USA), 4) Hemin + IgG. The
dose of the anti-TLR4 antibody was determined as pre-
viously described [32]. The release of TNF-a, IL-1b and
IL-6 was analyzed by ELISA.
Anti-TLR4 monoclonal antibody
We used anti-mouse TLR4 monoclonal antibody to neu-
tralize TLR4 in mice. Mice were divided into four
groups (n = 6): 1) WT mice injected with saline, 2)
TLR4
−/− mice, 3) WT mice injected with anti-TLR4
antibody, and 4) WT mice injected with control anti-
body IgG2a. For antibody administration, 200 μgo f
anti-mouse TLR4 monoclonal unconjugated antibody
Mts510 (LifeSpan BioSciences, Seattle, WA, USA) were
injected i.v. immediately after ICH. Mice in group 4)
received class-match control rat anti-mouse mAb
(IgG2a,2 0 0μg/mL, LifeSpan Biosciences, Seattle, WA,
USA). The dose of antibodies used was based on our
previous findings [34]. Cerebral water content and
extent of neurological impairment were measured 3
d a y sa f t e rI C H .M e a n w h i l e ,E L I S Aw a su s e dt oa s s e s s
expression of TNF-a, IL-1b and IL-6 in damaged tissue.
Macrophage infiltration was evaluated with CD68
immunohistochemistry.
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Results were shown as mean ± standard deviation (SD).
Multiple groups were compared using one-way or two-
way analysis of variance and Student-Newman-Keuls
test in post hoc tests. Statistical Package for the Social
Sciences (SPSS) 11.5 software (Chicago, IL, USA) was
used for statistical analyses. A probability value (p)<
0.05 was deemed statistically significant.
Results
ICH-induced TLR4 upregulation in perihematoma brain
tissues
To explore the role of TLR4 in inflammation after ICH,
we first analyzed TLR4 mRNA expression on day 1, 2,
3, and 5 post-ICH using a real-time RT-PCR. The result
showed that TLR4 mRNA was significantly upregulated
in perihematoma brain tissues following ICH at all
tested time-points when compared to sham-operated
control mice (Figure 1A). TLR4 mRNA expression
peaked on day 3 (P < 0. 01) and started decreasing on
day 5 (P 0. 01). We next performed double-immuno-
fluorescence staining to assess cellular expression of
TLR4. Anti-tubilin, anti-GFAP, and anti-CD11b, respec-
tively, were used as cell marker for neuron (Figure 1B),
astrocyte (Figure 1C) and microglial cell (Figure 1D),
respectively. We found that TLR4 expressed in all these
cell types and the protein expression was significantly
upregulated when compared to that of the sham group
(P < 0.01; Figure 1B-D. Consistent with the TLR4
mRNA upregulation, TLR4 expression also peaked on
day 3 and began decreasing on day 5 following ICH.
Although both neuron and reactive astrocyte exhibited
TLR4 expression, double-fluorescent staining showed
that TLR4 predominantly expressed in CD11b-positive
cells.
TLR4
−/− mice showed significantly lower levels of
inflammation and neurological impairment following ICH
To further assess the role of TLR4 in the inflammatory
cascade in response to ICH, we employed TLR4 knock-
out mice (TLR4
−/−). We induced ICH in TLR4
−/− mice
and then evaluated brain damage and neurological
impairments 3 days after ICH when we observed the
maximum upregulation of TLR4 in WT mice with ICH.
Compared to WT mice, TLR4
−/− mice showed a signifi-
cantly lower brain water content (P < 0.01, n = 3, Figure
2A) and neurological deficit scores (NDS) (P < 0.01, n =
3, Figure 2B). These suggested that TLR4
−/− mice had
less extent of neurological impairments after ICH. Next,
we detected inflammatory cytokines expression in TLR4
−/− mice after ICH. ELISA showed that TLR4
−/− mice
exhibited significantly lower (P < 0.01, n = 3) expression
of IL-6, TNF-a,a n dI L - 1 b in perihematoma tissues 3
days after ICH (Figure 2C). Finally, we examined
macrophage infiltration in perihematoma tissues and
found that the extent of macrophage infiltration is dra-
matically decreased (P <0 . 0 1 ,n =3 ,F i g u r e2 D )a s
shown in decreased CD68-positive cells (arrows in Fig-
ure 2D) in 20 consecutive high-power fields (20 HPFs)
obtained from the perihematoma region.
TLR4-mediated inflammation after ICH via MyD88/TRIF
signaling pathway and NF-B activation
It has been established that TLR4 exerts its functions
through intracytoplasmic TIR domain-containing adap-
tors, such as MyD88 and TRIF. MyD88, a common TIR
domain-containing adaptor, is essential for the induction
of inflammatory cytokines triggered by TLR4 [16,17].
TRIF is implicated in the TLR4-mediated MyD88-inde-
pendent pathway. Both MyD88 and TRIF modulate
TLR4-mediated activation of immunity and inflamma-
tion. To investigate which signal pathway is involved in
TLR4-mediated inflammatory response after ICH, we
employed MyD88
−/− and TRIF
−/− mice.
First, we evaluated the extent of ICH-induced brain
damage and inflammatory responses in MyD88
−/− and
TRIF
−/− mice. We found that compared to WT mice,
both MyD88
−/− and TRIF
−/− mice had significantly less
impairments after ICH, indicated by decreased cerebral
water content (Figure 3A) and lower neurological deficit
score (Figure 3B). Furthermore, we quantified inflamma-
tory cytokine expression and macrophage infiltration in
perihematoma tissues of these mice. ELISA showed that
3 days after ICH WT mice displayed dramatic increase
in TNF-a,I L - 1 b, and IL-6 levels compared to the sham
group. On the contrary, both MyD88
−/− and TRIF
−/−
exhibited significant lower expression of these cytokines
compared to WT mice, although significantly higher
than the sham control (Figure 3C). This suggested that
depletion of either MyD88 or TRIF dramatically sup-
pressed ICH-induced cytokine expression. Reduced
inflammation in these mice was also supported by the
observation that MyD88
−/− and TRIF
−/− had significantly
lower macrophage infiltration compared to WT mice, as
shown in reduced CD68-positive cells (P < 0.01) in peri-
hematoma tissues (Figure 3D). Taken together, these
findings indicate that both MyD88 and TRIF signaling
pathway might be involved in the TLR4-mediated
inflammatory process following ICH.
T oa s kw h e t h e rM y D 8 8o rT R I Fi st h ed o w n s t r e a m
pathway in TLR4-mediated inflammation following ICH,
we assessed MyD88 and TRIF protein expression in
perihematoma tissues from TLR4
−/− and WT mice.
Western blot results showed that WT mice showed a
significant increase in MyD88 and TRIF protein expres-
sion in response to ICH injury, while TLR4
−/− mice had
much lower MyD88 and TRIF expression compared to
WT mice at all tested time-points (P < 0.01, Figure 4A
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tion triggered both MyD88 andT R I Fe x p r e s s i o n ,w h i l e
abolishing TLR4-suppressed ICH-induced MyD88 and
TRIF upregulation.
Activation of transcription factor NF-Bi sad o w n -
stream event of the TLR4/MyD88 signaling pathway
[16,17]. NF-B plays a critical role in the inflammatory
response by translocating into the nucleus and
Figure 1 TLR4 mRNA and protein expression after ICH. A) Real-time RT-PCR shows an upregulation of TLR4 mRNA expression in
perihematoma tissues in WT mice (n = 6) on days 1, 2, 3, and 5 post ICH. B) TLR4 co-labeling with tubulin-positive neuron (arrows, n = 6). C)
TLR4 co-labeling with GFAP-positive astrocytes (arrows, n = 6). D) TLR4 co-labeling with CD11b-positive microglia. Compared to sham control
mice (n = 6), ICH induced significant increase in TLR4 protein. *P < 0.05, **P < 0.01 vs. sham control. Values (mean ± SD) are representative of
two independent experiments. Bar = 20 μM.
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We therefore compared NF-B activity in TLR4
−/− and
WT mice following ICH using an electrophoretic mobi-
lity shift assay, and found that ICH-induced increase of
NF-B activity in TLR4
−/− mice was significantly lower
than the increase in WT mice at all tested time-points
(P < 0. 01; Figure 4C). Overall, our results suggest that
MyD88 and TRIF might both participate in TLR4-
mediated inflammation in response to ICH via activa-
tion of NF-B and modulating expression of inflamma-
tory cytokines.
Heme potentiated microglia activation and induced TLR4-
mediated inflammatory injury
Heme and iron metabolism are of considerable impor-
tance in neuropathogenesis following traumatic injury
and hemorrhagic stroke [36]. Free heme is released
through hemoglobin lysis following an intracerebral
bleed, and then degraded by heme oxygenase to form
f r e ei r o n[ 7 ] .T h ea b o v ed a t as h o w e dt h a tT L R 4w a s
significantly upregulated in microglia following ICH,
however, the event that triggered the activation of TLR4
remained unclear. Free heme and iron are potent indu-
cers of inflammation, and are highly toxic to brain tis-
sues [6,10]. To test the hypothesis that heme and iron
trigger activation of TLR4 after ICH, we investigated the
effect of exogenous hemin and iron on the expression of
TLR4 and cytokine release in both in vitro and in vivo <
models. First, using primary cultured microglial cells, we
found that hemin treatment significantly increased
TLR4 expression (P < 0. 01) in cultured microglia while
bilirubin and FeSO4 showed no effect (Figure 5A).
Moreover, the expression of TNF-a by activated micro-
glia was significantly increased (P <0 . 0 1 ) .Am a j o rc o n -
cern when characterizing any putative ligand of TLR4,
especially in an endogenous environment, is the possible
presence of microbial derived contaminants. Determina-
tion of the content of endotoxin by the limulus assay
demonstrated that hemin preparations used in the study
were free of any detectable LPS. Furthermore, hemin
Figure 2 TLR4
−/− mice displayed attenuated brain injury and decreased neuroinflammation.T L R 4
−/− had decreased brain water content
(A, n = 3) and decreased NDS (B, n = 3). ELISA showed that TLR4
−/− mice had a marked decrease in release of IL-6, TNF-a, and IL-1b (C,n=3 )
on day 3 post-ICH. D) Immunohistochemistry of CD68 showed decreased macrophage infiltration in TLR4
−/− mice on day 3 post-ICH (n = 3). **P
< 0.01 vs. sham group;
##P <0 .0 1vs. WT group; Bar = 50 μM in D. Values (mean ± SD) are representative of three independent experiments.
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concentration that fully abolished the LPS effect. Hemin
also induced the secretion of TNF-a by microliga in the
presence of polymyxin B (Figure 5B).
Next, we investigated the effects of hemin stimulation
on microglia culture derived from TLR4
−/− mice. We
observed that administration of hemin significantly
induced the expression of TNF-a,I L - 1 b,a n dI L - 6( F i g -
ure 5C) in microglia from WT mice but not from TLR4
−/− mice, suggesting that TLR4 depletion suppressed
hemin-stimulated microglial activation. Co-administra-
tion of hemin with anti-TLR4 antibody to WT
Figure 3 Declined neurologic deficits and inflammation in MyD88
−/− and TRIF
−/− mice. Compared to WT mice, both MyD88
−/− and TRIF
−/− mice had decreased brain water content (A), NDS (B), (C) Both MyD88
−/− and TRIF
−/− mice showed decreased protein levels of IL-6, TNF-a,
and IL-1b, and (D) immunohistochemistry of CD68 showed decreased macrophage infiltration in the perihematoma region of MyD88
−/− and
TRIF
−/− brain on day3 post-ICH. **P < 0.01 vs. sham group;
##P <0 .0 1vs. WT group.
$$P < 0.01 vs. WT group, Bar = 50 μM in D. Values (mean ±
SD, n = 3 for each group) are representative of three independent experiments.
Figure 4 TLR4
−/− mice showed reduced MyD88 and TRIF protein level and NF-B activity. Western blot showed TLR4
−/− had decreased
expression of MyD88 (A) and TRIF (B). Electrophoretic mobility shift assay showed decreased NF-B activity in TLR4
−/− (C)* * P < 0.01 vs. sham
group,
##P <0 .0 1vs. WT group. Values (mean ± SD, n = 3 for each group) are representative of three independent experiments.
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TNF-a,I L - 1 b,a n dI L - 6( F i g u r e5 C ) .C o - a d m i n i s t r a t i o n
of IgG as a control for anti-TLR4 antibody showed no
effect. These data suggest that heme might potentiate
microglial activation P < TLR4 and both genetic deple-
tion and antibody neutralization of TLR4 in microglial
cells lead to suppression in heme-induced microglial
activation.
To test the hypothesis that heme causes TLR4-
mediated inflammatory injury after ICH, we further
examined the effect of exogenous hemin application in
the mouse model. Hemin was stereotactically injected
into the striatum in WT and TLR4
−/− mice. One day
after injection, we evaluated the extent of brain injury
and inflammation as described above. Our data showed
that administration of hemin dramatically induced brain
damage in WT mice, as demonstrated in significant
increase in brain water content (P < 0.01, n =6 ,F i g u r e
5D) and NDS (P <0 . 0 1 ,n = 6, Figure 5D) of WT mice.
However, the deteriorating effect of hemin was not
found in TLR4
−/− mice as no obvious change was
detected in brain water content and NDS. Meanwhile,
Figure 5 Heme stimulates microglia activation and induces brain inflammatory injury via TLR4.( A) Stimulation with bilirubin, Hemin and
FeSO4 influenced TLR4 expression on cultured microglial cells. **P < 0.01 vs. control group (n =6 )( B) TNF-a release in microglial cells in
response to stimulus. **,
##P < 0.01 vs. control group,
$$P < 0.01 vs. LPS group (n = 6). (C) TNF-a, IL-1b, and IL-6 expression in microglial cells in
response to stimulus. **P < 0.01 vs. control group,
##, $$P < 0.01 vs. WT group, n = 6. Hemin treatment decreased brain water content (D) and
NDS (D) in TLR4
−/− mice. **P < 0.01 vs. control group,
##P < 0.01 vs. WT group n =6 .( E) Hemin treatment increased cytokines release in TLR4
−/−
mice. **P < 0.01 vs. control group,
##P < 0.01 vs. WT group n = 6. Values (mean ± SD) are representative of two independent experiments.
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Page 9 of 14IL-6, TNF-a,a n dI L - 1 b expression increased signifi-
cantly in perihematoma tissues of WT mice after hemin
injection (Figure 5E) but not in TLR4
−/− mice, suggest-
ing that depletion of TLR4 suppressed the hemin-
induced inflammatory process after ICH. Together with
in vitro data, these findings suggest that heme might
trigger TLR4-mediated inflammatory injury following
ICH possibly through activating microglial cell and
inflammatory response, an dd e p l e t i o no fT L R 4c o u l d
protect ICH brain from heme-induced-brain damage.
TLR4 monoclonal antibody conferred significant
neuroprotection following ICH
The above experiments showed a beneficial effect of
TLR4 depletion in ICH-induced brain damage. In our
previous study, we also showed that intravenous admin-
istration of anti-TLR4 antibody 30 min prior to occlu-
sion of the middle cerebral artery attenuated ischemia-
reperfusion damage and improved mice behavioral per-
formance [34]. In this study, we were interested in
assessing the effect of neutralizing TLR4 using Mts510
in mice with ICH. We found that mice that received
Mts510 showed significantly lower cerebral water con-
tent (Figure 6A) and neurological impairments (Figure
6B) compared to WT mice and WT mice with IgG con-
trol. This antibody-mediated neuroprotection effect was
similar to the observation in TLR4
−/− mice. Antibody
administration prior to ICH also showed inhibition of
cytokine expression (Figure 6C) and macrophage infil-
tration (Figure 6D), indicating a reduced inflammatory
process in TLR4-depleted mice. These results indicate
that administration of anti-TLR4 monoclonal antibody
prior to ICH exhibits significant neuroprotection, which
possibly acts through suppression of cytokine expression
and macrophage infiltration in the damaged region of
the ICH brain.
Discussion
Inflammatory injury plays an important role in ICH-
induced neurological deficit. However, the signaling
pathways by which the upstream cellular events trigger
innate immune and inflammatory responses that
Figure 6 Administration of anti-TLR4 monoclonal antibody immediately after ICH provided neuroprotection. Administration of antibody
against TLR4 in WT mice of ICH decreased brain water content (A) and NDS (B). Administration of antibody against TLR4 in WT mice
significantly decreased cytokine release (C) and macrophage infiltration (D) in response to ICH. **P < 0.01 vs. WT group. Scale bar = 50 μM (D).
Values (mean ± SD, n = 6 for each group) are representative of three independent experiments.
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ent. Teng et al. [21] reported that TLR4 and NF-B
were unregulated in perihematoma tissues, suggesting
that TLR4 signaling was involved in ICH-induced brain
injury. In the present study, we explored the role of
TLR4 in ICH-induced inflammatory injury and tested
the hypothesis that heme and iron, products of erythro-
cyte lysis, could trigger TLR4-mediated inflammatory
damage via activation of NF-Bd u r i n gI C H .W ef o u n d
that ICH significantly upregulates TLR4 expression in
microglial cells and induces NF-B activity possibly via
the MyD88/TRIF signaling pathway, which modulates
cytokine expression and macrophage infiltration and
results in inflammatory damage (Figure 7). We further
showed that after ICH heme triggers TLR4-mediated
inflammatory injury. Neutralizing TLR4 with antibody at
the time of ICH provides beneficial neuroprotection. To
our knowledge, the present study demonstrates, for the
first time, that heme induces TLR4 activation which
might be an upstream event in the inflammatory process
in response to ICH, suggesting that TLR4 is a promising
target for prevention and therapeutic treatment of ICH.
Previous studies indicated that TLR4 is expressed in
many type cells, like macrophage, hepatocyte and renal
tubular cells [29,37,38]. In CNS, TLR4 has been
reported to be expressed in both microglia and
astrocytes, and even in neurons [39-41]. In accordance
with previous results, we found that TLR4 expression
increased markedly in microglial cells, indicating its
involvement in ICH-induced inflammation. Our data
also showed expression of TLR4 in neurons and astro-
cytes in perihematoma tissue, suggesting TLR4 in neu-
rons and astrocytes may also play a role in the disease.
The possible role of TLR4 in neurons and astrocytes in
neuroinflammation of ICH needs to be further explored.
The TLR signaling pathway arises from intracytoplas-
mic TIR domains, which contain adaptors such as
MyD88 and TRIF. MyD88 is essential for the induction
of inflammatory cytokines whereas TRIF is mainly
implicated in the TLR3- and TLR4-mediated MyD88-
independent pathway [42,43]. Both MyD88 and TRIF
can modulate TLR4-mediated inflammation. The ICH
model in transgenic mice showed that abolishing of
MyD88 and TRIF, respectively, led to reduced neurolo-
gical deficits and reduced cytokine release and macro-
phage infiltration, which were similar to what we
observed in TLR4
−/− mice. A reduced expression of
MyD88 and TRIF in TLR4−/− mice in response to ICH
injury is direct evidence of the involvement of MyD88
and TRIF in the TLR4 signaling pathway after ICH.
Moreover, concomitant decrease in NF-B activity was
observed with a decrease in MyD88 and TRIF
Figure 7 Schematic diagram of the Heme/TLR4/MyD88 and/or TRIF hypothesis in ICH. Heme activates TLR4-mediated inflammatory injury
via the MyD88/TRIF signaling pathway in intracerebral hemorrhage mouse brain.
Lin et al. Journal of Neuroinflammation 2012, 9:46
http://www.jneuroinflammation.com/content/9/1/46
Page 11 of 14expression. In summary, this suggests that both MyD88
and TRIF are involved in TLR4-mediated inflammation
after ICH and deletion of TLR4 suppresses ICH-induced
activation of its downstream signaling pathway which in
WT mice might contribute to inflammation-related neu-
rological deficits. Our previous study showed that only
the MyD88 but not the TRIF pathway was involved in
TLR4-mediated ischemia damage [31], suggesting that
although TLR4 participates in both ischemia- and
hemorrhage-induced brain injury, the underlying signal-
ing pathway is different. The downstream pathway
involved in TLR4 activation may depend on the type of
brain injury and initiating factors.
Free heme is released during erythrocyte lysis, and
then degraded by heme oxygenase to form iron [7,44].
Morphologically, red cells maintain their biconcave
shape for several days following ICH (~2 days in rats)
[45]. In vitro, red cell lysis occurs slowly with the release
of oxyhemoglobin starting after 2 days [46]. Accumula-
tion of heme and iron in the perihematoma region is
characterized by neurotoxicity, and causes acute inflam-
mation through amplifying leukocyte activation and
upregulating the expression of adhesion molecules and
cytokine [44,47]. TLR4 has been identified as capable of
binding to heme, and inducing TNF-a secretion [21]. In
light of our observation of TLR4-mediated inflammatory
injury after ICH, we therefore propose that accumula-
tion of heme in perhematorma region might trigger
TLR4-mediated inflammation in the ICH context. We
test this hypothesis using both cultured microglia and
transgenic mice models. In vitro studies showed that
hemin induced TLR4 overexpression in microglial cells,
but iron did not. Moreover, the expression of TNF-a by
activated microglia was significantly increased only by
hemin. Meanwhile, our results also showed that hemin
induced microglia to release inflammatory factors via
TLR4. This suggests a direct correlation between TLR4
and hemin-induced microglial activation, which was
further supported by the observation that application of
TLR4 antibody suppressed hemin-induced microglial
activation. Previously, Figueiredo et al. [21] reported
that only hemin but not Fe
2+ could activate macro-
phages via TLR4 to produce TNF-a,w h i c hw a sc o n s i s -
tent with our results. However, Figueiredo et al. report
that the monoclonal antibody (Mts510) did not block
hemin-induced TLR4 activation in macrophages, rather
it only blocks LPS induction, which was not consistent
with our results. The discrepancy could be due to the
different reagent used in the experiments. Endotoxin
(LPS) contamination in the reagent could possibly affect
experimental results. In order to exam the possible pre-
sence of endotoxin in heme reagents, the endotoxin
level was determined using a standard endotoxin-speci-
fic Limulus amebocyte lysate reagent. The level of
endotoxin in heme was 0.01 endotoxin units (1 EU/mL),
which ruled out any effect of endotoxin. Therefore, our
experimental results are not due to endotoxin contami-
nation. The reason for the discrepancy was unclear,
thus, the mechanism of heme in neuroinflammation of
ICH needs to be further explored.
We further used an in vivo model to investigate the
effect of heme-caused brain inflammation in the context
of ICH. We found that exogenous administration of
hemin induced inflammation in WT mice, while it had
no marked effect on TLR4
−/− mice. Taken together with
culture study, our data suggest that heme causes micro-
glia activation and induces NF-B activation via the
TLR4/MyD88 and TRIF signaling pathway, and then
induces neuroinflammation in ICH.
Finally, administration of TLR4 antibody to disrupt
TLR4 signaling following ICH resulted in a neuroprotec-
tive effect, confirming a central role of TLR4 in ICH-
induced inflammatory injury and suggests that TLR4
could be a potential therapeutic target in prevention and
treatment of ICH.
Conclusions
In conclusion, our findings reveal that heme triggers
TLR4-mediated inflammatory injury via the MyD88/
TRIF signaling pathway in intracerebral hemorrhage in
mouse brain. This study suggests a central role of TLR4
in ICH-induced brain damage and provides a potential
therapeutic target in prevention and treatment of ICH.
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